Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines
Product Brochure
Pain O Soma 350mg Tablets
₹ 42/Strip
Strength
350mg
Packaging Sizes
10*10 Tablets
Packaging Types
Box
Composition
Carisoprodol 350mg
Shelf Life
36 Months
Usage
Muscle Relaxant and Pain Killer
Treatment
Treat Moderate to Severe Acute Pain in Adults
Manufacturer
HAB
Form
Tablets
Availability
In Stock
Pain-O-Soma 350mg Tablet is a muscle relaxer. It eases the discomfort brought on by musculoskeletal diseases that are painful and rigid, such as muscle spasms, tension, rigidity, and rigidity.
Exports To: United States Of America | United Kingdom | Australia | Canada | France
Find products similar to Pain O Soma 350mg Tablets
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
16-03-2021
Legal Status of Firm
Proprietorship
Nature of Business
Service Provider and Others
Number of Employees
11 To 25 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
Oct 2024
GST
07GBPPP0145B1ZR
Import Export Code (IEC)
GBPPP*****
Exports to
United States Of America | United Kingdom | Australia | Canada | France
Established in the year of 2021, In India We are operating with the name of Buy Your Meds, we are the Top Most Distributer and Wholeseller of Various Medicines and Pharma Products. Buy Your Meds is our wholly and solely Brand name throught which we connect with our Importing Partners from the end to end of the Globe. We Presents “Buy Your Meds" are a Exporter of an extensive array Erectile Dysfunction medicine , Tapentadol Tablets, Ivermectine Tablets etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.For our accomplishment story, we are grateful to our Mr. Sameer, whose continual backing and directions have been useful to us for attaining exponential development in the current market.
